Twist Bioscience Corporation logo

TWST

NASDAQ

Twist Bioscience Corporation

SectorHealth CareIndustryBiotechnology: Biological Products (No Diagnostic Substances)IPO2018
$58.80-4.39 (-6.95%)
Website
News25/Ratings12

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with ImmunoPrecise Antibodies Ltd.; Victorian Clinical Genetic Services; Vivlion GmbH; and Kyowa Kirin Pharmaceutical Research, Inc. Twist Bioscience Corporation was founded in 2013 and is headquartered in South San Francisco, California.

News · 26 weeks121-42%
2025-10-26: 72025-11-02: 152025-11-09: 42025-11-16: 92025-11-23: 62025-11-30: 12025-12-07: 42025-12-14: 12025-12-21: 42025-12-28: 02026-01-04: 22026-01-11: 52026-01-18: 02026-01-25: 12026-02-01: 132026-02-08: 122026-02-15: 92026-02-22: 92026-03-01: 12026-03-08: 42026-03-15: 32026-03-22: 42026-03-29: 12026-04-05: 12026-04-12: 22026-04-19: 3
2025-10-262026-04-19
Mix6390d
  • Insider39(62%)
  • SEC Filings13(21%)
  • Other8(13%)
  • Earnings3(5%)

Latest news

25 items